stockrowMedtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025.
- Revenue
- +13.7%
- EPS
- +42.0%
- Free cash flow
- +120.9%
- Total debt
- −1.59%
Quarter to July 2026, against a year earlier
Follow MDT
Alert me
Medtronic PLC (MDT) Free cash flow margin
Medtronic PLC's free cash flow margin over the twelve months to 31 July 2026 was 16.3%, up 1.4 percentage points from fiscal 2026 (14.9%). Over the past ten years it has ranged from 12.1% (fiscal 2018) to 21.4% (fiscal 2015); the current reading is higher than 33% of that period. That is above the Medical Devices industry median of −3.88% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2026 | 14.9% | (0.54) |
| FY2025 | 15.5% | (0.61) |
| FY2024 | 16.1% | 1.40 |
| FY2023 | 14.7% | (4.20) |
| FY2022 | 18.9% | 2.65 |
| FY2021 | 16.2% | (4.60) |
| FY2020 | 20.8% | 1.60 |
| FY2019 | 19.2% | 7.15 |
| FY2018 | 12.1% | (6.87) |
| FY2017 | 18.9% | 4.47 |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| DXCM DexCom, Inc. compare | 21.5% |
| EW Edwards Lifesciences Corporation compare | 21.3% |
| STE STERIS plc compare | 20.9% |
| SYK Stryker Corporation compare | 16.8% |
| MDT Medtronic PLC | 16.3% |
| BSX Boston Scientific Corporation compare | 15.8% |
| PHG Koninklijke Philips N.V. compare | 10.3% |
| GEHC GE HealthCare Technologies Inc. compare | 8.73% |
| ABT Abbott Laboratories compare | 0.00% |
| Medical Devices industry median | −3.88% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on MDT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement